Home > Insider Trading > Filing (0001138723-19-000046)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1138723	Accuray Inc	ARAY	Surgical & Medical Instruments & Apparatus (3841)	770268932

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1159917	Joshua Levine	1310 Chesapeake Terrace Sunnyvale CA 94089	President & Ceo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2019-10-31	28,081	$2.61	931,063	No	4	S	Direct
Common Stock	Acquisiton	2019-10-31	418,490	$0.00	1,349,553	No	4	A	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	A	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Acquisiton	2019-10-31	923,020	$0.00	923,020	$2.60

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
923,020		2029-10-31	No	4	A	Direct

Footnotes

Shares were automatically sold in accordance with Accuray policy for all restricted stock unit (RSU) releases in order to cover tax obligations upon RSU release and is consistent with Accuray practices for all RSU releases of employees located in the United States.
Fiscal year 2020 Performance award with Performance Measurement Period from 7/1/2019 to 6/30/2020. If the performance metrics are met the vesting will occur on the last day of the quarter for two years beginning 9/30/2020 contingent on continued employment.
The options are exercisable as they vest. A total of 25% of the entire number of shares subject to this stock option becomes vested and fully exercisable on the first anniversary of the vesting commencement date and the remaining shares subject to this stock option vest and become exercisable in equal monthly installments, ratably over the following 36 months.